Localizing the sentinel node in cutaneous melanoma: Gamma probe detection versus blue dye

Annals of Surgical Oncology

Volumn 4, Issue 2, 1997, Pages 156-160

  Kapteijn, B Acca E ^a   Nieweg, Omgo E ^a   Liem, IngHan ^a   Mooi, Wolter J ^a   Balm, Alfons J M ^a   Muller, Sara H ^a   Peterse, Johannes L ^a   Valdés Olmos, Renato A ^a   Hoefnagel, Cornells A ^a   Kroon, Bin B R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Gamma detection probe; Melanoma; Patent blue dye; Sentinel node

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; DISULFINE BLUE; FUCHSINE; MACROSALB TC 99M; TECHNETIUM TC 99M NANOCOLLOID;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; ROSANILINE DYES; SKIN NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0031089510     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303799     Document Type: Article

References (22)

1. Balch CM, Soong SJ, Shaw HM, et al. Changing trends in the clinical and pathologic features of melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous melanoma. 2nd ed. Philadelphia: JB Lippincott, 1992:40-5.
2. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627-30.
3. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-30.
4. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697-705.
5. Kroon BBR, Jonk A. Elective lymph node dissection in melanoma: still a controversial issue. Neth J Surg 1991;43:129-32.
6. Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol 1988;6:163-72.
7. Drepper H, Kohler CO, Bastian B, et al. Benefit of elective lymph node dissection in subgroups of melanoma patients. Cancer 1993;72:741-9.
8. Karakousis CP, Emrich LJ, Rao U. Groin dissection in malignant melanoma. Am J Surg 1986;152:491-5.
9. McNeer G, Das Gupta TK. Prognosis in malignant melanoma. Surgery 1964;56:512-8.
10. Urist MM, Maddox NVA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983;51:2152-6.
11. Ames FC, Singletary SE. Cutaneous malignancies of the trunk and lower extremities. In: Johnson DE, Ames FC, eds. Groin dissection. Chicago: Year Book Medical, 1985:111-36.
12. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 1986;73:906-8.
13. Baas PC, Schraffordt Koops H, Hoekstra HJ, Van Bruggen JJ, Van der Weele LT, Oldhoff J. Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg 1992;127:281-6.
14. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992:127:392-9.
15. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
16. Lingam MK, Mackie RM, Mackay AJ. Intraoperative lymphatic mapping using patent blue V dye to identify nodal micrometastases in malignant melanoma. Reg Cancer Treat 1994;7:144-6.
17. Reinigen D, Cruse CW, Wells K, et al. The orderly progression of melanoma metastases. Ann Surg 1994;220:759-67.
18. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
19. Essner R, Foshag L, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjunct of intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. Abstract presented at the Society of Surgical Oncology 47th Annual Meeting, Houston, 1994;47:104.
20. Godellas CV, Berman CG, Lyman G, et al. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surgeon 1995;61:97-101.
21. Kapteijn BAE, Nieweg OE, Valdés Olmos RA, et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996;37:972-975.
22. Mudun A, Murray D, Herda S, et al. Reproducibility of lymphoscintigraphy and intraoperative surgical probe use to identify the sentinel node in patients with melanoma [Abstract]. J. Nucl Med 1995;36:263.